APAC Biotech, established in 2009, specializes in personalized dendritic cell-based cancer immunotherapy, approved by the Indian Health Regulatory.
APCEDEN®
LTR-Memvaxraleucel™
Patent/IP
Process
Keep My Tumor
Gallery
Research Paper
Newsletters
Career
FAQ
Contact
69, Jacaranda Marg, DLF Phase 2, Gurugram-122002 Monday to Friday 9:30 AM - 6:00 PM, Saturday 9:30 AM - 1:30 PM
+91-124-4207575
info@apacbiotech.com
Copyright © 2019 by APAC Biotech. All Rights Reserved.